ChristopherJosephLehmannMD
Infectious Disease • Chicago, ILTransplant/Immunocompromised States
Assistant Professor
Dr. Lehmann is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5641 South Maryland Ave.
Chicago, IL 60637
Education & Training
Indiana University School of MedicineResidency, Internal Medicine/Pediatrics, 2015 - 2019- Indiana University School of MedicineClass of 2015
Certifications & Licensure
IL State Medical License 2019 - 2026
IN State Medical License 2015 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Infectious Diseases
Publications & Presentations
PubMed
- Fidaxomicin versus oral vancomycin forinfection among patients at high risk for recurrence based on real-world experience.Natasha N Pettit, Alison K Lew, Cynthia T Nguyen, Elizabeth Bell, Christopher J Lehmann
Infection Control and Hospital Epidemiology. 2024-10-04 - 4 citationsFecal metabolite profiling identifies liver transplant recipients at risk for postoperative infection.Christopher J Lehmann, Nicholas P Dylla, Matthew Odenwald, Ravi Nayak, Maryam Khalid
Cell Host & Microbe. 2024-01-10 - 15 citationsBifidobacteria metabolize lactulose to optimize gut metabolites and prevent systemic infection in patients with liver disease.Matthew A Odenwald, Huaiying Lin, Christopher Lehmann, Nicholas P Dylla, Cody G Cole
Nature Microbiology. 2023-11-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
